SE460334B - Farmaceutiska preparat, innefattande humant insulin och human c-peptid - Google Patents

Farmaceutiska preparat, innefattande humant insulin och human c-peptid

Info

Publication number
SE460334B
SE460334B SE8204873A SE8204873A SE460334B SE 460334 B SE460334 B SE 460334B SE 8204873 A SE8204873 A SE 8204873A SE 8204873 A SE8204873 A SE 8204873A SE 460334 B SE460334 B SE 460334B
Authority
SE
Sweden
Prior art keywords
human
peptide
insulin
units
composition
Prior art date
Application number
SE8204873A
Other languages
English (en)
Swedish (sv)
Other versions
SE8204873L (sv
SE8204873D0 (sv
Inventor
R E Chance
B H Frank
J A Galloway
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of SE8204873D0 publication Critical patent/SE8204873D0/xx
Publication of SE8204873L publication Critical patent/SE8204873L/
Publication of SE460334B publication Critical patent/SE460334B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
SE8204873A 1981-08-27 1982-08-25 Farmaceutiska preparat, innefattande humant insulin och human c-peptid SE460334B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29671581A 1981-08-27 1981-08-27

Publications (3)

Publication Number Publication Date
SE8204873D0 SE8204873D0 (sv) 1982-08-25
SE8204873L SE8204873L (sv) 1983-02-28
SE460334B true SE460334B (sv) 1989-10-02

Family

ID=23143238

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8204873A SE460334B (sv) 1981-08-27 1982-08-25 Farmaceutiska preparat, innefattande humant insulin och human c-peptid

Country Status (20)

Country Link
JP (1) JPS5846024A (fr)
AU (1) AU551879B2 (fr)
BE (1) BE894185A (fr)
CA (1) CA1176158A (fr)
CH (1) CH650679A5 (fr)
DE (1) DE3232034A1 (fr)
DZ (1) DZ452A1 (fr)
FR (1) FR2513126B1 (fr)
GB (1) GB2104382B (fr)
IE (1) IE54119B1 (fr)
IL (1) IL66611A0 (fr)
IT (1) IT1153182B (fr)
LU (1) LU84359A1 (fr)
MW (1) MW3882A1 (fr)
NL (1) NL192192C (fr)
NZ (1) NZ201682A (fr)
PH (1) PH19361A (fr)
SE (1) SE460334B (fr)
ZA (1) ZA826159B (fr)
ZW (1) ZW17482A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7964558B2 (en) 2003-10-13 2011-06-21 La Jolla Therapeutic applications for C-peptide
EP2898900A1 (fr) 2008-09-19 2015-07-29 Nektar Therapeutics Conjugués polymères de ziconotide

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3326473A1 (de) * 1983-07-22 1985-01-31 Hoechst Ag, 6230 Frankfurt Pharmazeutisches mittel zur behandlung des diabetes mellitus
CA1296253C (fr) * 1986-10-20 1992-02-25 Praveen Tyle Compositions d'hormones de croissance stabilisees
AU8175387A (en) * 1986-10-20 1988-05-06 Novo Industri A/S Protamine zinc insulin preparations
DE3880346T2 (de) * 1987-02-25 1993-07-29 Novonordisk As Insulinderivate.
US5212154A (en) * 1987-08-14 1993-05-18 Akzo N.V. Preparation for treating complications in diabetes
EP0303308B1 (fr) * 1987-08-14 1991-05-29 Akzo N.V. Préparation pour prévenir ou combattre des complications dans le diabète
SE520392C2 (sv) 1996-09-27 2003-07-01 Creative Peptides Sweden Ab C Specifika peptider för behandling av diabetes mellitus
CN101060856B (zh) * 2004-11-22 2011-01-19 诺和诺德公司 可溶、稳定的含胰岛素制剂
GB0511269D0 (en) 2005-06-02 2005-07-13 Creative Peptides Sweden Ab Sustained release preparation of pro-insulin C-peptide
GB0601950D0 (en) * 2006-01-31 2006-03-15 Creative Peptides Sweden Ab Compositions and methods of treating diabetes
NZ603399A (en) 2010-05-17 2014-09-26 Cebix Inc Pegylated c-peptide
WO2013075117A2 (fr) 2011-11-17 2013-05-23 John Wahren Peptide c pegylé

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2789080A (en) * 1952-08-14 1957-04-16 Christensen Henry Marinus Insulin-albumin compositions
CH330318A (de) * 1953-09-08 1958-05-31 British Drug Houses Ltd Verfahren zur Herstellung eines Insulinpräparates mit verlängerter Wirkungszeit

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7964558B2 (en) 2003-10-13 2011-06-21 La Jolla Therapeutic applications for C-peptide
EP2898900A1 (fr) 2008-09-19 2015-07-29 Nektar Therapeutics Conjugués polymères de ziconotide

Also Published As

Publication number Publication date
BE894185A (fr) 1983-02-24
ZW17482A1 (en) 1982-11-17
MW3882A1 (en) 1984-07-11
FR2513126B1 (fr) 1986-04-18
FR2513126A1 (fr) 1983-03-25
IT8223017A0 (it) 1982-08-27
CA1176158A (fr) 1984-10-16
AU551879B2 (en) 1986-05-15
DZ452A1 (fr) 2004-09-13
SE8204873L (sv) 1983-02-28
IE54119B1 (en) 1989-06-21
ZA826159B (en) 1984-04-25
IT1153182B (it) 1987-01-14
GB2104382A (en) 1983-03-09
DE3232034C2 (fr) 1991-04-11
CH650679A5 (de) 1985-08-15
PH19361A (en) 1986-04-02
IL66611A0 (en) 1982-12-31
NZ201682A (en) 1985-08-16
NL192192C (nl) 1997-03-04
NL192192B (nl) 1996-11-01
GB2104382B (en) 1984-12-19
NL8203315A (nl) 1983-03-16
LU84359A1 (fr) 1983-02-28
IE822064L (en) 1983-02-27
IT8223017A1 (it) 1984-02-27
DE3232034A1 (de) 1983-03-10
SE8204873D0 (sv) 1982-08-25
JPS5846024A (ja) 1983-03-17
AU8759482A (en) 1983-03-03

Similar Documents

Publication Publication Date Title
EP2041169B1 (fr) Insuline glargine amidifiée
US5922675A (en) Acylated Insulin Analogs
FI79786C (fi) Foerfarande foer framstaellning ett farmaceutiskt medel foer behandling av diabetes.
US7291594B2 (en) GLP-1 derivative and preparation thereof absorbable via mucous membrane
US20120184488A1 (en) Insulin analogues of enhanced receptor-binding specificity
CZ295964B6 (cs) Nové deriváty inzulinu s rychlým začátkem působení, způsob jejich přípravy a farmaceutický prostředek, který je obsahuje
EP2254905A2 (fr) Analogues de l insuline stabilisés une protéase
Dimaline et al. Potent stimulation of the avian exocrine pancreas by porcine and chicken vasoactive intestinal peptide.
CA1176161A (fr) Composes pharmaceutiques contenant de l'insuline humaine et de la proinsuline
HU203840B (en) Process for producing mixed cristals suspension and mixed cristals containing native insuline and basically modificated insuline and injectable composition contining them
KR20050036865A (ko) 당뇨병 치료를 위한 조성물 및 방법
NL8203315A (nl) Farmaceutische preparaten, die menselijk insuline en menselijk c-peptide bevatten.
US20010041786A1 (en) Stabilized acylated insulin formulations
JP4402296B2 (ja) 亜鉛結合性が増大された新規なインスリン同族体
Skyler Insulin pharmacology
CA1176159A (fr) Compose pharmaceutique contenant de l'insuline humaine, un c-peptide et de la pro-insuline
JPS5846023A (ja) ヒトプロインシユリン製剤
JPH10330285A (ja) 血糖降下剤
AU673147B2 (en) Amylin agonist peptides and uses therefor
Tan et al. Differential insulin responses to oral and intravenous glucose in the transplantable rat insulinoma—a role for GIP

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8204873-7

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8204873-7

Format of ref document f/p: F